Character Biosciences
PrivateLast Round
Series B
Extension
Sep 17, 2025
Est. Valuation
$197M
Total Funding Raised
$138M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Character Biosciences is a biotechnology company that develops precision medicine and targeted therapies for progressive polygenic diseases, with an initial focus on ophthalmology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Character Biosciences Comparables
Compare Character Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomics | 77% | |
| Recursion Pharmaceuticals | 73% | |
| Maze Therapeutics | 70% | |
Character Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 17, 2025 | ||||
| Series B | Mar 25, 2025 | ||||
| Series A | May 17, 2022 | ||||
| Seed | Mar 1, 2020 |
Character Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A, Series B |
| Cantos Ventures | Series A, Seed |
| Innovation Endeavors | Series B Extension, Series B, Series A |
| Lifeforce Capital | Series A, Seed |
| Catalio Capital Management | Series B Extension, Series A, Series B |
| LUMA Partners | Series B |
| Jefferson Life Sciences | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 143% MoM.
- Jun 24, 2026
Grew 16% QoQ, from 49 to 57 employees.
Character Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Character Biosciences's valuation, stock price, and market status.